Tratamiento médico de la obesidad mórbida: alternativas actuales, límites y perspectivas

Seidell, 1995, Obesity in Europe: scaling an epidemic, Int J Obes, 19, 1 Pi-Sunyer, 1993, Medical hazards of obesity, Ann Intern Med, 119, 655, 10.7326/0003-4819-119-7_Part_2-199310011-00006 Must, 1999, Colditz G, Dietz WH. The disease burden associated with overweight and obesity, JAMA, 282, 1523, 10.1001/jama.282.16.1523 Mokdad, 2003, Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76 1999 Calle, 1999, Body mass index and mortality in a prospective cohort of U.S. adults, N Engl J Med, 341, 1097, 10.1056/NEJM199910073411501 Peeters, 2003, Obesity in adulthood and its consequences for life expectancy: a life-table analysis, Ann Intern Med, 138, 24, 10.7326/0003-4819-138-1-200301070-00008 Fontaine, 2003, Years of life lost due to obesity, JAMA, 289, 187, 10.1001/jama.289.2.187 Aranceta, 2003, Prevalencia de obesidad en España: resultados del estudio SEEDO 2000, Med Clin (Barc), 120, 608, 10.1157/13046926 Divisón, 1998, Prevalencia de obesidad y su relación con el riesgo cardiovascular en la población general de Albacete, Aten Primaria, 21, 205 De Pablos Velasco, 2002, Prevalence of obesity in a canarian community. Association with type 2 diabetes mellitus: the Guía Study, Eur J Clin Nutr, 56, 557, 10.1038/sj.ejcn.1601401 Matamoros, 2001, Prevalencia de obesidad en Madrid, Endocrinología, 48, 130 1998, NHLBI Obesity Task Force. guidelines on the identification Clinical evaluation,treatment of overweight in adults – The evidence report, Obes Res, 6, S51 Miller, 1997, A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention, Int J Obes, 21, 941, 10.1038/sj.ijo.0800499 Hitchcock Noël, 2002, Management of overweight and obese adults, BMJ, 325, 757, 10.1136/bmj.325.7367.757 Pi-Sunyer, 1996, A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity, Clin Ther, 18, 1006, 10.1016/S0149-2918(96)80057-9 Hill, 1998, Psychological health in a non-clinical sample of obese women, Int J Obes, 22, 578, 10.1038/sj.ijo.0800631 Gluck, 2001, Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients, Obes Res, 9, 264, 10.1038/oby.2001.31 Freedman, 2001, Popular diets: a scientific review, Obes Rev, 9, S1, 10.1038/oby.2001.113 Lightman, 1995, Discrepancy between selfreported and actual intake and exercise in obese subjects, N Engl J Med, 332, 621 Pirozzo, 2003, Should we recommended low-fats diets for obesity?, Obes Rev, 4, 83, 10.1046/j.1467-789X.2003.00099.x Astrup, 2000, The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies, Int J Obes, 24, 1545, 10.1038/sj.ijo.0801453 Hajduk, 2001, Dietary treatment of obesity, Curr Opin Endocrinol Diabetes, 8, 240, 10.1097/00060793-200110000-00003 Saris, 2000, Randomized controlled trial of changes in dietary carbohydrate trial of changes in dietary carbohydrate/ fat ratio and simple vs complex carbohydrates on body weight and blood lipids: the CARMEN study, Int J Obes, 24, 1310, 10.1038/sj.ijo.0801451 Bray, 1998, Dietary fat intake does affect obesity, Am J Clin Nutr, 68, 1157, 10.1093/ajcn/68.6.1157 Bravata, 2003, Efficacy and safety of low-carbohydrate diets. A systematic review, JAMA, 289, 1837, 10.1001/jama.289.14.1837 Brehm, 2003, A randomized trial comparing a very low carbohydrate diet and calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women, J Clin Endocrinol Metabol, 88, 1617, 10.1210/jc.2002-021480 Foster, 2003, A randomized trial of low-carbohydrate diet for obesity, N Engl J Med, 348, 2082, 10.1056/NEJMoa022207 Samaha, 2003, A low-carbohydrate as compared with a low-fat diet in severe obesity, N Engl J Med, 348, 2074, 10.1056/NEJMoa022637 Bray, 2003, Low-carbohydrate diets and realities of weight loss, JAMA, 289, 1853, 10.1001/jama.289.14.1853 Mcinni, 2003, Counseling for physical activity in overweight and obese patients, Am Family Physician, 67, 1249 Wing, 2001, Succesful weight loss maintenance, Annu Rev Nutr, 21, 323, 10.1146/annurev.nutr.21.1.323 Ayyad, 2000, Long-term efficacy of dietary treatment of obesity: a systematic review of the studies published between 1931 and 1999, Obes Rev, 1, 113, 10.1046/j.1467-789x.2000.00019.x Leung, 2003, Weight management and current options in pharmacotherapy: orlistat and sibutramime, Clin Ther, 25, 58, 10.1016/S0149-2918(03)90009-9 James, 2000, Effect of sibutramine on weight maintenance after weight loss: a randomised trial, Lancet, 356, 2119, 10.1016/S0140-6736(00)03491-7 Wirth, 2001, Long-term weight loss with sibutramine. A randomized controlled trial, JAMA, 286, 1331, 10.1001/jama.286.11.1331 Smith, 2001, Randomised placebo control trial of long term treatment with sibutramine in mild to moderate obesity, J Fam Pract, 50, 505 Barkeling, 2003, Short-term effects of sibutramine on appetite and eating behaviour and the long-term therapeutic outcome, Int J Obes, 27, 693, 10.1038/sj.ijo.0802298 Sjögström, 1998, Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients, Lancet, 352, 167, 10.1016/S0140-6736(97)11509-4 Davidson, 1999, Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controled trial, JAMA, 281, 235, 10.1001/jama.281.3.235 Krempf, 2003, Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity, Int J Obes, 27, 591, 10.1038/sj.ijo.0802281 McElroy, 2003, Topiramate in the treatment of binge eating disorder associated with obesity. A randomized, placebo-controlled trial, Am J Psychiatry, 160, 255, 10.1176/appi.ajp.160.2.255 Bray, 2003, A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity, Obes Res, 11, 722, 10.1038/oby.2003.102 Gadde, 2001, Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women, Obes Res, 9, 544, 10.1038/oby.2001.71 Anderson, 2002, Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial, Obes Res, 10, 633, 10.1038/oby.2002.86 Jain, 2002, Bupropion SR vs placebo for weight loss in obese patients with depressive symptoms, Obes Res, 10, 1049, 10.1038/oby.2002.142 Halpern, 2003, Treatment of obesity: an update on antiobesity medications, Obes Rev, 4, 25, 10.1046/j.1467-789X.2003.00083.x Weigle, 2003, Pharmacological therapy of obesity: past, present, and future, J Clin Endocrinol Metab, 88, 2462, 10.1210/jc.2003-030151 Donnelly, 2003, Researching new treatments for obesity: from neuroscience to inflammation, Diabetes Obes Metab, 5, 1, 10.1046/j.1463-1326.2003.00245.x Wadden, 1989, Treatment of obesity by very calorie diet, behaviour therapy, and their combination: a five-year perspective, Int J Obes, 13, 39 Pi-Sunyer, 1992, The role of very-low-calorie diets in obesity, Am J Clin Nutr, 56, S240S, 10.1093/ajcn/56.1.240S Foster, 1992, A controlled comparison of three very-low calorie-diets: effects on weight, body composition, and symptoms, Am J Clin Nutr, 55, 811, 10.1093/ajcn/55.4.811 Rössner, 1997, VLCD versus LCD in long-term treatment of obesity, Int J Obes, 21, 22, 10.1038/sj.ijo.0800355 Torgerson, 1999, Effects on body weight of strict or liberal adherence to an initial period of VLED treatment. A randomised, one year clinical trial of obese subjects, Int J Obes, 23, 190, 10.1038/sj.ijo.0800816 Rössner, 1998, Intermittent vs continuous VLCD therapy in obesity treatment, Int J Obes, 22, 190, 10.1038/sj.ijo.0800563 Heymsfield, 2003, Weight management using a meal replacement strategy: meta and pooling analysis from six studies, Int J Obes, 27, 537, 10.1038/sj.ijo.0802258 Mustajoki, 2001, Very low energy diets in the treatment of obesity, Obes Rev, 2, 61, 10.1046/j.1467-789x.2001.00026.x Anderson, 1992, Benefits and risks of an intensive very-low calorie diets program for severe obesity, Am J Gastroenterol, 87, 6 Dindo, 2003, Obesity in general elective surgery, Lancet, 361, 2032, 10.1016/S0140-6736(03)13640-9 Wahlen, 2001, The Bioenterics intragastric balloon (BIB): how to use it, Obes Surg, 11, 524, 10.1381/096089201321209468 Lindor, 1987, Intragastric balloons in comparison with standard therapy for obesity – A randomized, doubled-blind trial, Mayo Clin Proc, 62, 992, 10.1016/S0025-6196(12)65069-1 Mathus-Vliegen, 1990, Intragastric baloons for morbid obesity: results, patient tolerance and baloon life span, Br J Surg, 77, 76, 10.1002/bjs.1800770127 Mathus-Vliegen, 1990, Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-mililiter baloon, Gastroenterology, 99, 362, 10.1016/0016-5085(90)91017-Z Loffredo, 2001, Three years experience with the new intragastric balloon, and preoperative test for success with restrictive surgery, Obes Surg, 11, 330, 10.1381/096089201321336700 Totte, 2001, Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon, Obes Surg, 11, 519, 10.1381/096089201321209459 Evans, 2001, Intragastric balloon in the treatment of patients with morbid obesity, Br J Surg, 88, 1245, 10.1046/j.0007-1323.2001.01840.x Doldi, 2002, Treatment of morbid obesity with intragastric baloon in association with diet, Obes Surg, 12, 583, 10.1381/096089202762252398